Next "Impact" Series Webinar: How to build a PhysioPD™ model

How to build a PhysioPD™ model by Rebecca Baillie, PhD Rosa & Co June 20, 2011 12:00 - 1:00 pm EDT You are invited to attend Dr. Baillie's webinar How to build a PhysioPD model on June 20, 2011 at 12:00 pm EDT (GMT -5:00). Dr. Baillie's talk will explore the development of a PhysioPD model from scoping to incorporation of the mathematics. She will focus on how the models are designed, the science integrated, and the mathematics implemented into the selected pathways as well as the parameters and rates. Dr. Baillie's presentation is a part of the monthly world-wide webinar series “Impact of Modeling & Simulation in Drug Development” hosted by Rosa & Co. LLC. The purpose of the “Impact” series is to foster the use of M&S activities in all phases of drug development by illustrating the advantages and enhancing the applicability of M&S in product discovery, development, and marketing programs. The series is intended for drug development project team members from discovery to phase 4 clinical trials. This includes pharmacologists, ADME scientists, PK/PD modelers, clinical pharmacologists, clinical development team members, regulatory affairs specialists, and other interested professionals. Register for this free webinar at www.rosaandco.com/webinar. After registering you will receive a confirmation email containing information about joining the webinar. More information about the webinar series, an archive of past webinars, and a list of future webinar speakers may be found at www.rosaandco.com/webinar. Please allow 5-10 minutes for a Java applet to be installed on your computer prior to joining our webinar series for the first time. Toufigh Gordi, PhD President, PK/PD and Clinical Pharmacology Services Rosa & Co. LLC: www.rosaandco.com E-mail: [email protected] Tel.: 408-480-7314 Fax: 408-370-9810 The information contained in this e-mail message, e-mail message sequence, and/or any enclosures is confidential, and it may be privileged and protected from unauthorized use and/or disclosure. If you are not the intended recipient, any use, dissemination, distribution, or copying is strictly prohibited. If you received this e-mail in error, PLEASE NOTIFY THE SENDER immediately and destroy this message, any enclosures, and any copies of the message and/or the enclosures. Thank you.